[ascct] Workshop June 26-27: BioMed21: a Human Pathway-Based Approach to Medicine and Disease

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Thu, 25 May 2017 17:34:55 +0000


June 26 – 27, 2017
NIH Building, 5635 Fishers Lane, Bethesda, MD
Registration: https://ntp.niehs.nih.gov/go/biomed21

Objective: The objective of this workshop is to explore existing systems 
biology projects and approaches and how these projects might be better 
coordinated to optimally improve disease understanding and interventions.

Summary: Despite investment of billions of dollars over the past few decades, 
development of new drugs and other potential disease interventions remains 
elusive and immensely expensive. There is a growing recognition that, to 
increase the drug development success rate, a stronger focus on human-relevant 
data is needed. This data will support implementation of more relevant, 
efficient methods to understand chemical toxicity based on understanding and 
functionalizing human biological pathways. A number of projects are underway 
internationally to mine literature, collect data, and develop these adverse 
outcome pathways. This workshop is intended to bring representatives from 
several of these projects to a single venue to identify barriers and 
opportunities and make recommendations regarding what is needed to achieve the 
goal of fully implementing a human systems-biology platform for understanding 
disease and improving interventions.

Organizing Committee: Chris Austin (NCATS/NIH), Brian Berridge (GSK), Warren 
Casey (NIEHS/NIH), Suzy Fitzpatrick (FDA), Robert Kavlock (EPA), Troy Seidle 
(HSI), Anton Simeonov (NCATS/NIH), Dan Tagle (NCATS/NIH), Catherine Willett 

Organizers: The Human Toxicology Project Consortium and the National Institute 
of Environmental Health Sciences


PNG image

PNG image

Other related posts:

  • » [ascct] Workshop June 26-27: BioMed21: a Human Pathway-Based Approach to Medicine and Disease - Kristie Sullivan